154 related articles for article (PubMed ID: 37878724)
1. A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors.
Lin FT; Liu K; Garan LAW; Folly-Kossi H; Song Y; Lin SJ; Lin WC
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2307793120. PubMed ID: 37878724
[TBL] [Abstract][Full Text] [Related]
2. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity.
Moudry P; Watanabe K; Wolanin KM; Bartkova J; Wassing IE; Watanabe S; Strauss R; Troelsgaard Pedersen R; Oestergaard VH; Lisby M; Andújar-Sánchez M; Maya-Mendoza A; Esashi F; Lukas J; Bartek J
J Cell Biol; 2016 Feb; 212(3):281-8. PubMed ID: 26811421
[TBL] [Abstract][Full Text] [Related]
3. The DNA topoisomerase IIbeta binding protein 1 (TopBP1) interacts with poly (ADP-ribose) polymerase (PARP-1).
Wollmann Y; Schmidt U; Wieland GD; Zipfel PF; Saluz HP; Hänel F
J Cell Biochem; 2007 Sep; 102(1):171-82. PubMed ID: 17340632
[TBL] [Abstract][Full Text] [Related]
4. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.
Liu K; Ling S; Lin WC
Mol Cell Biol; 2011 Nov; 31(22):4464-81. PubMed ID: 21930790
[TBL] [Abstract][Full Text] [Related]
5. Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.
Liu K; Bellam N; Lin HY; Wang B; Stockard CR; Grizzle WE; Lin WC
Mol Cell Biol; 2009 May; 29(10):2673-93. PubMed ID: 19289498
[TBL] [Abstract][Full Text] [Related]
6. TOPBP1 regulates resistance of gastric cancer to oxaliplatin by promoting transcription of PARP1.
Fang Z; Gong C; Ye Z; Wang W; Zhu M; Hu Y; Liu Z; Zhou W; Li H
DNA Repair (Amst); 2022 Mar; 111():103278. PubMed ID: 35124372
[TBL] [Abstract][Full Text] [Related]
7. Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1.
Herold S; Hock A; Herkert B; Berns K; Mullenders J; Beijersbergen R; Bernards R; Eilers M
EMBO J; 2008 Nov; 27(21):2851-61. PubMed ID: 18923429
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.
Liu K; Lin FT; Graves JD; Lee YJ; Lin WC
Proc Natl Acad Sci U S A; 2017 May; 114(19):E3766-E3775. PubMed ID: 28439015
[TBL] [Abstract][Full Text] [Related]
9. Insights from the crystal structure of the sixth BRCT domain of topoisomerase IIbeta binding protein 1.
Leung CC; Kellogg E; Kuhnert A; Hänel F; Baker D; Glover JN
Protein Sci; 2010 Jan; 19(1):162-7. PubMed ID: 19937654
[TBL] [Abstract][Full Text] [Related]
10. TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53.
Lv Y; Huo Y; Yu X; Liu R; Zhang S; Zheng X; Zhang X
Drug Des Devel Ther; 2016; 10():3053-3064. PubMed ID: 27729767
[TBL] [Abstract][Full Text] [Related]
11. Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy.
Chowdhury P; Lin GE; Liu K; Song Y; Lin FT; Lin WC
Nat Commun; 2014 Nov; 5():5476. PubMed ID: 25400145
[TBL] [Abstract][Full Text] [Related]
12. Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway.
Lv Y; Liu R; Xie S; Zheng X; Mao J; Cai Y; Chen W
Anticancer Drugs; 2017 Sep; 28(8):861-868. PubMed ID: 28628491
[TBL] [Abstract][Full Text] [Related]
13. Regulation of E2F1 by BRCT domain-containing protein TopBP1.
Liu K; Lin FT; Ruppert JM; Lin WC
Mol Cell Biol; 2003 May; 23(9):3287-304. PubMed ID: 12697828
[TBL] [Abstract][Full Text] [Related]
14. Regulation of TopBP1 oligomerization by Akt/PKB for cell survival.
Liu K; Paik JC; Wang B; Lin FT; Lin WC
EMBO J; 2006 Oct; 25(20):4795-807. PubMed ID: 17006541
[TBL] [Abstract][Full Text] [Related]
15. Akt switches TopBP1 function from checkpoint activation to transcriptional regulation through phosphoserine binding-mediated oligomerization.
Liu K; Graves JD; Scott JD; Li R; Lin WC
Mol Cell Biol; 2013 Dec; 33(23):4685-700. PubMed ID: 24081328
[TBL] [Abstract][Full Text] [Related]
16. TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.
Liu K; Luo Y; Lin FT; Lin WC
Genes Dev; 2004 Mar; 18(6):673-86. PubMed ID: 15075294
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control.
Leung CC; Gong Z; Chen J; Glover JN
J Biol Chem; 2011 Feb; 286(6):4292-301. PubMed ID: 21127055
[TBL] [Abstract][Full Text] [Related]
18. Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers.
Putri JF; Bhargava P; Dhanjal JK; Yaguchi T; Sundar D; Kaul SC; Wadhwa R
J Exp Clin Cancer Res; 2019 Dec; 38(1):499. PubMed ID: 31856867
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation.
Blackford AN; Patel RN; Forrester NA; Theil K; Groitl P; Stewart GS; Taylor AM; Morgan IM; Dobner T; Grand RJ; Turnell AS
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12251-6. PubMed ID: 20566845
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase IIβ-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation.
Hong S; Xu J; Li Y; Andrade J; Hoover P; Kaminski PJ; Laimins LA
Oncogene; 2019 Apr; 38(17):3274-3287. PubMed ID: 30631149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
